icon-folder.gif   Conference Reports for NATAP  
  Reported by Jules Levin
IDWeek Oct 26-30
New Orleans 2016
Back grey_arrow_rt.gif
Direct Acting Anti-Viral Therapy for Chronic Hepatitis C Virus Infection Is Associated with Regression of Liver Fibrosis, Assessed by Serial Transient Elastography (Fibroscan)
  Reported by Jules Levin
IDWeek Oct 2016
Justin Chan1,5, Neliswa Gogela3, Hui Zheng4,5, Sara Lammert1,5, Tokunbo Ajayi2,5, Zachary Fricker2,5, Arthur Kim1,5, Gregory K. Robbins1,5, Raymond T. Chung2,5
Infectious Disease Unit1and Gastrointestinal Unit2, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
Division of Hepatology, Department of Medicine, University of Cape Town, Cape Town, South Africa3
Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA4 Harvard Medical School, Boston, MA5
 from Jules: this study was a followup of patients only 12 months after treatment, it takes years sometimes for the liver to improve so over time - 2 to years later Fibroscan results will improve for patients and the liver will slowly continually improve, after achieving an SVR.